Ellucian, the leading higher education technology solutions provider, today announced that the University of East London (UEL) will implement Banner, part of the Ellucian SaaS Platform. A new Ellucian ...

BioSpace has been compiling a list of the most innovative and exciting biotechs for a decade. Here we take a look back at ...

Exclusive by Chief Reporter Neal Keeling: "This donation is great for Salford - helping preserve the cultural legacy." ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A ...

Not only are Kamala Harris and Douglas Emhoff shredding political stereotypes, they are also—publicly and unabashedly—showing ...

Those under the Opella banner include seasonal allergy medication Allegra ... while GSK’s has fallen to just 4.2% ownership. Germany’s Merck KGaA sold off its consumer health unit to Proctor & Gamble ...

The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

Bengaluru: Merck has acquired Modifi Biosciences for as much as $1.3 billion, gaining access to its experimental cancer therapies, the privately held biotech firm said on Wednesday. As part of the ...